Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Plant-made Quadrivalent VLP Influenza Vaccine in Adults
NCT01991587Phase 2Completed
- Sponsor
- Medicago Inc.
- Start
- Oct 2013
- Primary completion
- Jun 2014
- Modality
- Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of plant-derived quadrivalent influenza virus-like particle vaccine in influenza, sponsored by Medicago Inc.. Started Oct 2013; status: completed.
02
Drugs
plant-derived quadrivalent influenza virus-like particle vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01991587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01991587.